Author pages are created from data sourced from our academic publisher partnerships and public sources.
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
IMPORTANCE Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at high risk for liver disease progression. However, interferon-based treatments for HCV… Expand
T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.
This study documents the differential requirements of T4+ T helper cells in the induction of virus-specific cytotoxic T-lymphocyte (CTL) and antibody responses during acute lymphocytic… Expand
Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.
- K. Osilla, G. Ryan, L. Bhatti, M. Goetz, M. Witt, G. Wagner
- AIDS patient care and STDs
- 21 December 2009
Liver disease is a leading cause of morbidity and mortality among patients coinfected with HIV and hepatitis C (HCV), yet few HIV coinfected patients actually receive HCV treatment. Providers must… Expand
Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial
Abstract Background: The safety and efficacy of weight-based ribavirin (RBV) dosing regimens in patients with HIV-HCV coinfection has not been demonstrated in randomized clinical trials. Objective:… Expand
Hepatitis C patients’ self‐reported adherence to treatment with pegylated interferon and ribavirin
- J. Weiss, L. Bhatti, +5 authors G. Wagner
- Alimentary pharmacology & therapeutics
- 1 August 2008
Aliment Pharmacol Ther 28, 289–293
Macular star in neuroretinitis.
Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients
Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment… Expand
Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes.
It was previously demonstrated that retinoic acid (RA) can enhance the functional responses of human T lymphocytes by increasing surface IL-2R alpha chain protein expression on proliferating T… Expand
Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.
- G. Wagner, G. Ryan, K. Osilla, L. Bhatti, M. Goetz, M. Witt
- AIDS patient care and STDs
- 9 September 2009
Liver disease is a leading cause of death among patients with HIV coinfected with hepatitis C (HCV); yet, studies show that less than 10% receive HCV treatment, in part because of limited treatment… Expand
Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial
Objective Simplification of antiretroviral therapy in patients with suppressed viremia may minimize long-term adverse effects. The study’s primary objective was to determine whether… Expand